These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 308934)

  • 1. Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression.
    Farrar WL; Elgert KD
    Int J Cancer; 1978 Aug; 22(2):142-51. PubMed ID: 308934
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. II. Mechanism of inhibition.
    Farrar WL; Elgert KD
    Cell Immunol; 1978 Oct; 40(2):365-75. PubMed ID: 309800
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells.
    Elgert KD; Farrar WL
    Cell Immunol; 1978 Oct; 40(2):356-64. PubMed ID: 309799
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic significance of nonspecific suppressor cells in spleens of tumor-bearing mice.
    Hanna N; Kripke ML
    Cell Immunol; 1979 Mar; 43(2):293-303. PubMed ID: 314343
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of murine tumors upon delayed hypersensitivity to dinitrochlorobenzene. II. Transitory delayed hypersensitivity in tumor-bearing mice.
    Jessup JM; Cohen MH
    J Natl Cancer Inst; 1977 Oct; 59(4):1221-6. PubMed ID: 903997
    [No Abstract]   [Full Text] [Related]  

  • 6. Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses.
    Garrigues HJ; Romero P; Hellström I; Hellström KE
    Cell Immunol; 1981 May; 60(1):109-18. PubMed ID: 6453654
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
    Elgert KD; Farrar WL
    J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and contact sensitivity to DNFA in mice. VIII. Identification of distinct T cell subpopulations that mediate in vivo and in vitro manifestations of delayed hypersensitivity.
    Moorhead JW
    J Immunol; 1978 Jan; 120(1):137-44. PubMed ID: 304865
    [No Abstract]   [Full Text] [Related]  

  • 10. Discussion paper: specific paralysis of the antitumor cellular immune response produced by growing tumors studied with a radioisotope footpad assay.
    Paranjpe MS; Boone CW; Takeichi N
    Ann N Y Acad Sci; 1976; 276():254-9. PubMed ID: 194516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative blastogenic regulation by tumor-bearing mouse T cells.
    Connolly KM; Elgert KD
    J Reticuloendothel Soc; 1980 Jul; 28(1):27-35. PubMed ID: 6446602
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. IV. Characterization of migration inhibition factor-producing lymphocytes and genetic requirements for activation.
    Moorhead JW; Murphy JW; Harvey RP; Hayes RL; Fetterhoff TJ
    Eur J Immunol; 1982 May; 12(5):431-6. PubMed ID: 7047175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
    Elgert KD; Connolly KM
    Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
    Poupon MF; Lespinats G; Kolb JP; Payelle B
    J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses in mice infected with lactic dehydrogenase virus. II. Contact sensitization to DNFB and characterization of lymphoid cells during acute LDV infection.
    Michaelides MC; Simms ES
    Cell Immunol; 1977 Mar; 29(2):285-94. PubMed ID: 301059
    [No Abstract]   [Full Text] [Related]  

  • 16. Soluble suppressor factor from the spleens of tumor-bearing mice.
    Subramanian C; Yu S; McKhann CF
    Cancer Res; 1978 Jul; 38(7):1996-2002. PubMed ID: 657137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity with hapten-modified lymphoid cells. II. Selective tolerance in F1 mice of T cell subsets recognizing 1-fluoro-2,4-dinitrobenzene associated with parental major histocompatibility complex antigens.
    Conlon PJ; Moorhead JW; Miller SD; Claman HN
    J Exp Med; 1980 Apr; 151(4):959-64. PubMed ID: 6966313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo suppression of syngeneic murine fibrosarcoma by macrophages and lymphocytes.
    Gupta N; Aikat BK; Sehgal S
    Indian J Med Res; 1982 Apr; 75():583-9. PubMed ID: 7106899
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.
    Moorhead JW
    J Immunol; 1976 Sep; 117(3):802-6. PubMed ID: 1085311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of contact allergy to DNFB in mice. I. Description of a model system.
    Claman HN; Jaffee BD
    J Immunol; 1983 Dec; 131(6):2682-6. PubMed ID: 6227661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.